296 related articles for article (PubMed ID: 18780318)
1. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
Vincens E; Balleyguier C; Rey A; Uzan C; Zareski E; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Cancer; 2008 Oct; 113(8):2158-65. PubMed ID: 18780318
[TBL] [Abstract][Full Text] [Related]
2. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
Delpech Y; Haie-Meder C; Rey A; Zafrani Y; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
Ann Surg Oncol; 2007 Nov; 14(11):3223-31. PubMed ID: 17713822
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
[TBL] [Abstract][Full Text] [Related]
4. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study.
Hequet D; Marchand E; Place V; Fourchotte V; De La Rochefordière A; Dridi S; Coutant C; Lecuru F; Bats AS; Koskas M; Bretel JJ; Bricou A; Delpech Y; Barranger E
Eur J Surg Oncol; 2013 Dec; 39(12):1428-34. PubMed ID: 24183796
[TBL] [Abstract][Full Text] [Related]
6. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma.
Azria E; Morice P; Haie-Meder C; Thoury A; Pautier P; Lhomme C; Duvillard P; Castaigne D
Ann Surg Oncol; 2005 Apr; 12(4):332-7. PubMed ID: 15827678
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
8. The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer.
Morice P; Uzan C; Zafrani Y; Delpech Y; Gouy S; Haie-Meder C
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S122-4. PubMed ID: 17761269
[TBL] [Abstract][Full Text] [Related]
9. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation.
Liu Y; Bai R; Sun H; Liu H; Zhao X; Li Y
Clin Radiol; 2009 Nov; 64(11):1067-74. PubMed ID: 19822239
[TBL] [Abstract][Full Text] [Related]
11. Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia?
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Balm AJ
Cancer; 2006 Apr; 106(8):1722-9. PubMed ID: 16544314
[TBL] [Abstract][Full Text] [Related]
12. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
[TBL] [Abstract][Full Text] [Related]
14. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer.
Marnitz S; Köhler C; Füller J; Hinkelbein W; Schneider A
Strahlenther Onkol; 2006 Jan; 182(1):45-51. PubMed ID: 16404520
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy.
Uzan C; Vincens E; Balleyguier C; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Int J Gynecol Cancer; 2010 Apr; 20(3):379-84. PubMed ID: 20375801
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension.
deSouza NM; Dina R; McIndoe GA; Soutter WP
Gynecol Oncol; 2006 Jul; 102(1):80-5. PubMed ID: 16427688
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D
Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754
[TBL] [Abstract][Full Text] [Related]
18. Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma.
Goksedef BP; Kunos C; Belinson JL; Rose PG
Am J Obstet Gynecol; 2009 Feb; 200(2):175.e1-5. PubMed ID: 19091305
[TBL] [Abstract][Full Text] [Related]
19. [Postoperative radiotherapy in patients with invasive uterine cervix cancer treated previously with simple hysterectomy. Results from the Hospital de Oncología, Centro Médico Nacional SXXI. ].
Huerta Bahena J; Labastida Almendaro S; Cortez Arroyo H; Calva A
Ginecol Obstet Mex; 2003 Jun; 71():304-11. PubMed ID: 14515661
[TBL] [Abstract][Full Text] [Related]
20. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
